chr9-5720172-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_020829.4(RIC1):c.441-10C>G variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.449 in 1,597,458 control chromosomes in the GnomAD database, including 170,450 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.40 ( 14109 hom., cov: 32)
Exomes 𝑓: 0.45 ( 156341 hom. )
Consequence
RIC1
NM_020829.4 splice_polypyrimidine_tract, intron
NM_020829.4 splice_polypyrimidine_tract, intron
Scores
2
Splicing: ADA: 0.001624
2
Clinical Significance
Conservation
PhyloP100: 1.33
Genes affected
RIC1 (HGNC:17686): (RIC1 homolog, RAB6A GEF complex partner 1) Enables guanyl-nucleotide exchange factor activity and small GTPase binding activity. Involved in several processes, including positive regulation of GTPase activity; regulation of extracellular matrix constituent secretion; and retrograde transport, endosome to Golgi. Located in cytosol and membrane. Part of Ric1-Rgp1 guanyl-nucleotide exchange factor complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 9-5720172-C-G is Benign according to our data. Variant chr9-5720172-C-G is described in ClinVar as [Benign]. Clinvar id is 1300068.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.85 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RIC1 | NM_020829.4 | c.441-10C>G | splice_polypyrimidine_tract_variant, intron_variant | ENST00000414202.7 | |||
LOC124902115 | XR_007061409.1 | n.15G>C | non_coding_transcript_exon_variant | 1/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RIC1 | ENST00000414202.7 | c.441-10C>G | splice_polypyrimidine_tract_variant, intron_variant | 5 | NM_020829.4 | P1 | |||
ENST00000426764.1 | n.65+8G>C | splice_region_variant, intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.404 AC: 61347AN: 151960Hom.: 14101 Cov.: 32
GnomAD3 genomes
AF:
AC:
61347
AN:
151960
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.502 AC: 125053AN: 249244Hom.: 33994 AF XY: 0.505 AC XY: 68000AN XY: 134664
GnomAD3 exomes
AF:
AC:
125053
AN:
249244
Hom.:
AF XY:
AC XY:
68000
AN XY:
134664
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.454 AC: 656630AN: 1445380Hom.: 156341 Cov.: 30 AF XY: 0.459 AC XY: 330248AN XY: 719876
GnomAD4 exome
AF:
AC:
656630
AN:
1445380
Hom.:
Cov.:
30
AF XY:
AC XY:
330248
AN XY:
719876
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.404 AC: 61368AN: 152078Hom.: 14109 Cov.: 32 AF XY: 0.415 AC XY: 30845AN XY: 74332
GnomAD4 genome
AF:
AC:
61368
AN:
152078
Hom.:
Cov.:
32
AF XY:
AC XY:
30845
AN XY:
74332
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2413
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Catifa syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 19, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at